Public-registry site landscape for NCT04773678, a Moderate to Severe Persistent Asthma study sponsored by Connect Biopharm LLC. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04773678 (registry record) |
| Sponsor | Connect Biopharm LLC |
| Condition(s) | Moderate to Severe Persistent Asthma |
| Phase | PHASE2 |
| Listed sites | 76 |
| Site countries | United States, China, Hungary, Poland, South Korea |
Eichor generates a preliminary site-risk snapshot for NCT04773678 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →